Following this puts new work involving it at the top of your briefing, with a note saying why it is there. Links are taken from the source record, never inferred.
A critical narrative review analyzing why candidate therapies for cancer therapy-related cognitive impairment fail to translate from preclinical to clinical settings, proposing methodological improvements and a translational roadmap rather than reporting original empirical findings.
A single-centre RCT with adequate design and clear positive primary endpoint results, but limited by modest sample size, short follow-up, and generalizability to one setting in China.
Cross-sectional observational study identifying symptom phenotypes and generating hypotheses about intervention targets through network analysis and computer simulation, without intervention trials or prospective validation.
First-in-vivo evidence from a single small animal study without clinical validation, demonstrating mechanism but requiring confirmation in larger preclinical and human studies before clinical application.
A well-designed RCT in an understudied population showing feasibility and safety of exercise during chemotherapy, with secondary benefits in strength preservation and toxicity reduction, though the primary fatigue endpoint was not met.
A scoping review mapping the landscape of non-pharmacological interventions without quality assessment, effect synthesis, or meta-analysis; descriptive and gap-identifying rather than outcome-determining.
Early-stage preclinical and animal study demonstrating analgesic efficacy of thymoquinone in paclitaxel-induced neuropathy, but with limited structural neuroprotection and no human data, requiring confirmation before clinical translation.
Systematic review and meta-analysis of 197 studies with 72,794 patients providing a pooled prevalence estimate with confidence interval; rigorous methodology but epidemiological rather than intervention-based evidence.